BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35435140)

  • 1. The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.
    Debédat J; Le Roy T; Voland L; Belda E; Alili R; Adriouch S; Bel Lassen P; Kasahara K; Hutchison E; Genser L; Torres L; Gamblin C; Rouault C; Zucker JD; Kapel N; Poitou C; Marcelin G; Rey FE; Aron-Wisnewsky J; Clément K
    Gut Microbes; 2022; 14(1):2050635. PubMed ID: 35435140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Contribution to Weight-Independent Glycemic Improvements after Gastric Bypass Surgery.
    Hankir MK; Kovatcheva-Datchary P; Springer R; Hoffmann A; Vogel J; Seyfried F; Arora T
    Microbiol Spectr; 2023 Jun; 11(3):e0510922. PubMed ID: 37022171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes.
    Liu H; Zhang H; Wang X; Yu X; Hu C; Zhang X
    Surg Obes Relat Dis; 2018 May; 14(5):584-593. PubMed ID: 29459013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.
    Murphy R; Tsai P; Jüllig M; Liu A; Plank L; Booth M
    Obes Surg; 2017 Apr; 27(4):917-925. PubMed ID: 27738970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery.
    Davies N; O'Sullivan JM; Plank LD; Murphy R
    Obes Surg; 2020 Sep; 30(9):3536-3548. PubMed ID: 32447634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D.
    Wang C; Zhang H; Liu H; Zhang H; Bao Y; Di J; Hu C
    Diabetes Res Clin Pract; 2020 Apr; 162():108116. PubMed ID: 32194221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes.
    Guo Y; Liu CQ; Shan CX; Chen Y; Li HH; Huang ZP; Zou DJ
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27572277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Gut Microbiome after Bariatric Surgery Versus Medical Weight Loss in a Pilot Randomized Trial.
    Lee CJ; Florea L; Sears CL; Maruthur N; Potter JJ; Schweitzer M; Magnuson T; Clark JM
    Obes Surg; 2019 Oct; 29(10):3239-3245. PubMed ID: 31256356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation.
    Ferraz ÁAB; de Sá VCT; Santa-Cruz F; Siqueira LT; Silva LB; Campos JM
    Surg Obes Relat Dis; 2019 May; 15(5):682-687. PubMed ID: 31005458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Presurgical Gut Microbial Diversity in Roux-en-Y Gastric Bypass Weight-Loss Response: A Cohort Study.
    Morán-Ramos S; Soriano-Cortés R; Soto-Fuentes V; Tenorio-Quiroz A; Gervasio-Ortiz E; Rico-Amador D; Herrera M; Sierra-Salazar M; Aguilar-Salinas CA; Antuna-Puente B; Rodríguez-Flores M
    Lifestyle Genom; 2024; 17(1):12-21. PubMed ID: 37992691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
    Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for type 2 diabetes: the case for Roux-en-Y gastric bypass.
    Spaniolas K; Pories WJ
    Surg Obes Relat Dis; 2016 Jul; 12(6):1220-4. PubMed ID: 27260652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gut microbial flora after Roux-en-Y gastric bypass and sleeve gastrectomy and their effects on post-operative weight loss.
    Karami R; Kermansaravi M; Pishgahroudsari M; Talebi M; Mohammadzadeh N; Pazouki A
    Updates Surg; 2021 Aug; 73(4):1493-1499. PubMed ID: 33067675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Gut Microbiota in Sustained Weight Loss Following Roux-en-Y Gastric Bypass Surgery.
    Fouladi F; Brooks AE; Fodor AA; Carroll IM; Bulik-Sullivan EC; Tsilimigras MCB; Sioda M; Steffen KJ
    Obes Surg; 2019 Apr; 29(4):1259-1267. PubMed ID: 30604078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric volume reduction is essential for the remission of type 2 diabetes mellitus after bariatric surgery in nonobese rats.
    Zhang X; Yu B; Yang D; Qiao Z; Cao T; Zhang P
    Surg Obes Relat Dis; 2016; 12(8):1569-1576. PubMed ID: 27425832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass.
    Hernández-Montoliu L; Rodríguez-Peña MM; Puig R; Astiarraga B; Guerrero-Pérez F; Virgili N; López-Urdiales R; Osorio J; Monseny R; Lazzara C; Sobrino L; Pérez-Maraver M; Pérez-Prieto M; Pellitero S; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Front Endocrinol (Lausanne); 2023; 14():1181744. PubMed ID: 37916149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota adaptation after weight loss by Roux-en-Y gastric bypass or sleeve gastrectomy bariatric surgeries.
    Sánchez-Alcoholado L; Gutiérrez-Repiso C; Gómez-Pérez AM; García-Fuentes E; Tinahones FJ; Moreno-Indias I
    Surg Obes Relat Dis; 2019 Nov; 15(11):1888-1895. PubMed ID: 31648978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.